The production of 'aerodynamically equivalent' drug and excipient inhalable powders using a novel fractionation technique

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 77, Issue 2, 2011, Pages 283-296

  Taki, Mohammed ^a   Marriott, Christopher ^a   Zeng, Xian Ming ^b   Martin, Gary P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b TEVA Pharmaceuticals   (United States)

Author keywords

Aerodynamic fractionation; Aerodynamically equivalent powders; Fluticasone propionate; Particle size distribution; Salmeterol xinafoate

Indexed keywords

ALPHA LACTOSE; EXCIPIENT; FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE;

AEROSOL; ARTICLE; CORRELATION ANALYSIS; DRUG FORMULATION; FRACTIONATION; PARTICLE SIZE; POWDER; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; BRONCHODILATOR AGENTS; CHEMICAL FRACTIONATION; CRYSTALLIZATION; DRUG COMPOUNDING; EXCIPIENTS; HUMANS; LACTOSE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS;

EID: 79551563573     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.11.021     Document Type: Article

References (50)

1. G. Buckton, A. Choularton, A.E. Beezer, and S.M. Chatham The effect of the comminution technique on the surface energy of a powder Int. J. Pharm. 47 1988 121 128
2. H. Steckel, N. Rasenack, and B.W. Muller In-situ-micronization of disodium cromoglycate for pulmonary delivery Eur. J. Pharm. Biopharm. 55 2003 173 180
3. L. Mackin, R. Zanon, J.M. Park, K. Foster, H. Opalenik, and M. Demonte Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry Int. J. Pharm. 231 2002 227 236
4. H.K. Chan, and N.Y.K. Chew Novel alternative methods for the delivery of drugs for the treatment of asthma Adv. Drug Del. Rev. 55 2003 793 805
5. X.M. Zeng, G.P. Martin, and C. Marriott Particulate Interactions in Dry Powder Formulations for Inhalation first ed. 2001 Taylor & Francis London, UK
6. M.T. Vidgren, P.A. Vidgren, and T.P. Paronen Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate Int. J. Pharm. 35 1987 139 144
7. P. Harjunen, V.P. Lehto, K. Martimo, E. Suihko, T. Lankinen, P. Paronen, and K. Jarvinen Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI Eur. J. Pharm. Sci. 16 2002 313 321
8. H. Larhrib, G.P. Martin, C. Marriott, and D. Prime The influence of carrier and drug morphology on drug delivery from dry powder formulations Int. J. Pharm. 257 2003 283 296
9. K. Ikegami, Y. Kawashima, H. Takeuchi, H. Yamamoto, N. Isshiki, D.I. Momose, and K. Ouchi Primary crystal growth during spherical agglomeration in liquid: designing an ideal dry powder inhalation system Powder Technol. 126 2002 266 274
10. N. Rasenack, H. Steckel, and B.W. Muller Micronization of anti-inflammatory drugs for pulmonary delivery by a controlled crystallization process J. Pharm. Sci. 92 2003 35 44
11. J.S. Kaerger, and R. Price Processing of spherical crystalline particles via a novel solution atomization and crystallization by sonication (SAXS) technique Pharm. Res. 21 2004 372 381
12. J.M. Lobo, H. Schiavone, S. Palakodaty, P. York, A. Clark, and S.T. Tzannis SCF-engineered powders for delivery of budesonide from passive DPI devices J. Pharm. Sci. 94 2005 2276 2288
13. H. Schiavone, S. Palakodaty, A. Clark, P. York, and S.T. Tzannis Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers Int. J. Pharm. 281 2004 55 66
14. M. Rehman, B.Y. Shekunov, P. York, D. Lechuga-Ballesteros, D.P. Miller, T. Tan, and P. Colthorpe Optimisation of powders for pulmonary delivery using supercritical fluid technology Eur. J. Pharm. Sci. 22 2004 1 17
15. B.Y. Shekunov, J.C. Feeley, A.H.L. Chow, H.H.Y. Tong, and P. York Aerosolisation behaviour of micronised and supercritically-processed powders J. Aerosol Sci. 34 2003 553 568
16. T.M. Crowder, J.A. Rosati, J.D. Schroeter, A.J. Hickey, and T.B. Martonen Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development Pharm. Res. 19 2002 239 245
17. C. Bosquillon, C. Lombry, V. Preat, and R. Vanbever Comparison of particle sizing techniques in the case of inhalation dry powders J. Pharm. Sci. 90 2001 2032 2041
18. D.L. French, D.A. Edwards, and R.W. Niven The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation J. Aerosol Sci. 27 1996 769 783
19. W.I. Li, M. Perzl, J. Heyder, R. Langer, J.D. Brain, K.H. Englmeier, R.W. Niven, and D.A. Edwards Aerodynamics and aerosol particle deaggregation phenomena in model oral-pharyngeal cavities J. Aerosol Sci. 27 1996 1269 1286
20. D. Prime, The SX and FP refractive index values, in, GSK, personal communication 2008.
21. H. Adi, I. Larson, and P. Stewart Laser diffraction particle sizing of cohesive lactose powders Powder Technol. 179 2007 90 94
22. Malvern Instruments Ltd., Data Sheet: QSpec dry powder feeder, 2008. < http://www.malvern.co.uk/LabEng/products/Mastersizer/MSS/qspec-dpf.htm > (accessed 25.06.08).
23. V.A. Marple, D.L. Roberts, F.J. Romay, N.C. Miller, K.G. Truman, M. Van Oort, B. Olsson, M.J. Holroyd, J.P. Mitchell, and D. Hochrainer Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: Design J. Aerosol Med.: Depos. Clearance Effects Lung 16 2003 283 299
24. J.P. Mitchell, and M.W. Nagel Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations J. Aerosol Med.: Depos. Clearance Effects Lung 16 2003 341 377
25. V.A. Marple, B.A. Olson, K. Santhanakrishnan, J.P. Mitchell, S.C. Murray, and B.L. Hudson-Curtis Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration J. Aerosol Med.: Depos. Clearance Effects Lung 16 2003 301 324
26. J.P. Mitchell, M.W. Nagel, K.J. Wiersema, and C.C. Doyle Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer AAPS Pharm. Sci. Technol. 4 4 2003 Article 54
27. A. Kamiya, M. Sakagami, M. Hindle, and P.R. Byron Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and next generation pharmaceutical impactors and their USP methods J. Pharm. Sci. 93 2004 1828 1837
28. Ph. Eur., Consistency of Formulated Preparations: Fine Particle Dose and Particle Size Distribution, in: European Pharmacopoeia, European Directorate for the Quality of Medicines and Healthcare, 2004.
29. International Organization for Standardization, Particle Size Analysis-Laser Diffraction Methods - Part 1: General Principles, 1999, ISO 13320-13321: 11999(E).
30. A. Beekman, D. Shan, A. Ali, W. Dai, S. Ward-Smith, and M. Goldenberg Micrometer-scale particle sizing by laser diffraction: critical impact of the imaginary component of refractive index Pharm. Res. 22 2005 518 522
31. W.T.J. Kwong, S.L. Ho, and A.L. Coates Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor J. Aerosol Med.: Depos. Clearance Effects Lung 13 2000 303 314
32. L. Vecellio None, D. Grimbert, M.H. Becquemin, E. Boissinot, A. Le Pape, E. Lemarie, and P. Diot Validation of laser diffraction method as a substitute for cascade impaction in the European project for a nebulizer standard J. Aerosol Med.: Depos. Clearance Effects Lung 14 2001 107 114
33. A. Haynes, M.S. Shaik, H. Krarup, and M. Singh Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers J. Pharm. Sci. 93 2004 349 363
34. H.D.C. Smyth, A.J. Hickey, Dynamic particle size distributions emitted from pMDIs as determined by laser diffraction: a function of time and space, in: R.N. Dalby, P.R. Byron, J. Peart, S.J. Farr (Eds.), Respiratory Drug Delivery VIII, Davis Harwood International, 2002.
35. G. Martin, H. MacRitchie, C. Marriott, and X.-M. Zeng Characterisation of a carrier-free dry powder aerosol formulation using inertial impaction and laser diffraction Pharm. Res. 23 2006 2210 2219
36. C. Marriott, H.B. MacRitchie, X.M. Zeng, and G.P. Martin Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations Int. J. Pharm. 326 2006 39 49
37. X.M. Zeng, H. MacRitchie, C. Marriott, and G. Martin Correlation between inertial impaction and laser diffraction sizing data for aerosolized carrier-based dry powder formulations Pharm. Res. 23 2006 2200 2209
38. A.H. de Boer, D. Gjaltema, P. Hagedoorn, and H.W. Frijlink Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique Int. J. Pharm. 249 2002 219 231
39. J. Mitchell, S. Newman, and H.K. Chan In vitro and in vitro aspects of cascade impactor tests and inhaler performance: a review AAPS Pharm. Sci. Technol. 8 4 2007
40. B.H. Kaye, D. Alliet, L. Switzer, and C. Turbitt-Daoust The effect of shape on intermethod correlation of techniques for characterizing the size distribution of powder. Part 1. Correlating the size distribution measured by sieving, image analysis, and diffractometer methods Particle Particle Syst Character 14 1997 219 224
41. B.H. Kaye, D. Alliet, L. Switzer, and C. Turbitt-Daoust The effect of shape on intermethod correlation of techniques for characterizing the size distribution of powder. Part 2: correlating the size distribution as measured by diffractometer methods TSI-Amherst aerosol spectrometer, and coulter counter Particle Particle Syst Character 16 1999 266 272
42. F.M. Etzler, and M.S. Sanderson Particle size analysis: a comparative study of various methods Particle Particle Syst Character 12 1995 217 224
43. R.N. Kelly, J. Kazanjian, Commercial reference shape standards use in the study of particle shape effect on laser diffraction particle size analysis, AAPS Pharm. Sci. Technol. 7 (2) (2006) E1-E12.
44. A.H.L. Chow, H.H.Y. Tong, P. Chattopadhyay, and B.Y. Shekunov Particle engineering for pulmonary drug delivery Pharm. Res. 24 2007 411 437
45. B.Y. Shekunov, J.C. Feeley, A.H.L. Chow, H.H.Y. Tong, and P. York Physical properties of supercritically-processed and micronised powders for respiratory drug delivery KONA 2002 178 187
46. D. Lu, and A.J. Hickey Liposomal dry powders as aerosols for pulmonary delivery of proteins AAPS Pharm. Sci. Technol. 6 4 2005 Article 80
47. M. Irngartinger, V. Camuglia, M. Damm, J. Goede, and H.W. Frijlink Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing Eur. J. Pharm. Biopharm. 58 2004 7 14
48. H. Steckel, N. Rasenack, P. Villax, and B.W. Muller In vitro characterization of jet-milled and in-situ-micronized fluticasone-17-propionate Int. J. Pharm. 258 2003 65 75
49. Y.F. Maa, P.A. Nguyen, J.D. Andya, N. Dasovich, T.D. Sweeney, S.J. Shire, and C.C. Hsu Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders Pharm. Res. 15 1998 768 775
50. H.K. Chan, A.R. Clark, J.C. Feeley, M.C. Kuo, S.R. Lehrman, K. Pikal-Cleland, D.P. Miller, R. Vehring, and D. Lechuga-Ballesteros Physical stability of salmon calcitonin spray-dried powders for inhalation J. Pharm. Sci. 93 2004 792 804